v3.26.1
Financial Instruments
6 Months Ended
Jun. 30, 2026
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments

NOTE 4 – FINANCIAL INSTRUMENTS

Non-marketable Equity Securities

As of June 30, 2026 and December 31, 2025, other noncurrent assets included equity securities accounted for under the equity method with a carrying amount of $4.6 million and $4.7 million, respectively. No impairments to the carrying amount of the Company’s non-marketable equity securities were recognized in the three and six months ended June 30, 2026 and 2025.

Derivative Instruments

The Company uses a foreign exchange hedging strategy to hedge local currency expenses and reduce variability associated with anticipated cash flows. The Company’s derivative financial instruments consist of foreign currency forward contracts. These contracts have maturities that are generally twelve months or less. Fair values for derivative financial instruments are based on prices computed using third-party valuation models. All the significant inputs to the third-party valuation models are observable

in active markets. Inputs include current market-based parameters such as forward rates, yield curves and credit default swap pricing.

Cash Flow Hedges

The Company designates its foreign currency forward contracts as cash flow hedges. The effective portion of the gain or loss on the derivatives are reported as a component of accumulated other comprehensive loss (“AOCL”) in stockholders’ equity and reclassified into net loss on the condensed consolidated statements of operations (unaudited) in the period the hedged transactions are settled.

The notional and fair values of all derivative financial instruments were as follows (in thousands):

 

Location in Balance Sheet

 

June 30, 2026

 

 

December 31, 2025

 

Derivative instruments designated as cash flow hedges:

 

 

 

 

 

 

 

Fair valueforeign exchange contract liabilities, net amount

Accrued liabilities

 

$

2,284

 

 

$

257

 

 

 

 

 

 

 

 

 

Notional value held to buy U.S. dollars in exchange for other currencies

 

 

$

1,811

 

 

$

8,196

 

Notional value held to sell U.S. dollars in exchange for other currencies

 

 

$

64,148

 

 

$

66,476

 

All of the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparty to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's condensed consolidated balance sheets on a net basis.

The gross amounts of the Company’s foreign currency forward contracts and the net amounts recorded in the Company’s condensed consolidated balance sheets were as follows (in thousands):

 

June 30, 2026

 

 

December 31, 2025

 

Gross amount of recognized assets

$

101

 

 

$

1,009

 

Gross amount of recognized liabilities

 

(2,385

)

 

 

(1,266

)

Net derivative liabilities

$

(2,284

)

 

$

(257

)

The changes in AOCL related to the cash flow hedges consisted of the following (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Beginning balance

 

$

(2,085

)

 

$

300

 

 

$

(257

)

 

$

(1,858

)

Other comprehensive (loss) income before reclassification

 

 

(689

)

 

 

2,677

 

 

 

(2,525

)

 

 

4,254

 

Amounts reclassified from accumulated other comprehensive loss (income) into net loss

 

 

490

 

 

 

(382

)

 

 

498

 

 

 

199

 

Net current period other comprehensive (loss) income

 

 

(199

)

 

 

2,295

 

 

 

(2,027

)

 

 

4,453

 

Ending balance

 

$

(2,284

)

 

$

2,595

 

 

$

(2,284

)

 

$

2,595

 

The following table summarizes the gains (losses) recognized upon settlement of the hedged transactions in the condensed consolidated statements of operations for three and six months ended June 30, 2026 and 2025 (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development

 

$

(376

)

 

$

379

 

 

$

(335

)

 

$

120

 

Selling, general and administrative

 

 

(114

)

 

 

76

 

 

 

(163

)

 

 

(30

)

Total

 

$

(490

)

 

$

455

 

 

$

(498

)

 

$

90